Association of Ideal Cardiovascular Health With Vascular Brain Injury and Incident Dementia

Stroke

Volumn 47, Issue 5, 2016, Pages 1201-1206

  Pase, Matthew P ^a,c   Beiser, Alexa ^a,d   Enserro, Danielle ^a,b   Xanthakis, Vanessa ^a,b   Aparicio, Hugo ^a,e   Satizabal, Claudia L ^a   Himali, Jayandra J ^a   Kase, Carlos S ^e   Vasan, Ramachandran S ^a,b   DeCarli, Charles ^f   Seshadri, Sudha ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Section of Preventive Medicine and Epidemiology   (United States)

^c SWINBURNE UNIVERSITY OF TECHNOLOGY   (Australia)

^d BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^e BOSTON MEDICAL CENTER   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

American Heart Association; brain; cerebrovascular disorders; epidemiology; risk factors

Indexed keywords

CHOLESTEROL; GLUCOSE;

ADULT; ALZHEIMER DISEASE; ARTICLE; ASSESSMENT OF HUMANS; BLOOD PRESSURE; BLOOD VESSEL INJURY; BODY MASS; BRAIN ATROPHY; BRAIN INJURY; CARDIOVASCULAR HEALTH SCORE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; COGNITIVE DEFECT; COHORT ANALYSIS; DEMENTIA; DIET; FEMALE; FRONTAL CORTEX; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL TASK; MULTIINFARCT DEMENTIA; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL ACTIVITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; VISUAL MEMORY; AGED; ATROPHY; CEREBROVASCULAR DISORDERS; CEREBROVASCULAR TRAUMA; HEALTH STATUS INDICATOR; INCIDENCE; MASSACHUSETTS; MEDICAL SOCIETY; MIDDLE AGED; PATHOLOGY; PROTOCOL COMPLIANCE; RISK; STROKE; UNITED STATES;

AGED; AMERICAN HEART ASSOCIATION; ATROPHY; CEREBROVASCULAR DISORDERS; CEREBROVASCULAR TRAUMA; COHORT STUDIES; DEMENTIA; FEMALE; GUIDELINE ADHERENCE; HEALTH STATUS INDICATORS; HUMANS; INCIDENCE; MALE; MASSACHUSETTS; MIDDLE AGED; RISK; STROKE; UNITED STATES;

EID: 84963700328     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.115.012608     Document Type: Article

References (27)

1. Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP. The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement. 2013;9:63-75.e2. doi: 10.1016/j.jalz.2012.11.007.
2. Alzheimer's Association. 2015 Alzheimer's disease facts and figures. Alzheimers Dement. 2015;11:332-384.
3. Yoshida D, Ninomiya T, Doi Y, Hata J, Fukuhara M, Ikeda F, et al. Prevalence and causes of functional disability in an elderly general population of Japanese: the Hisayama study. J Epidemiol. 2012;22:222-229.
4. Petersen RC, Roberts RO, Knopman DS, Geda YE, Cha RH, Pankratz VS, et al. Prevalence of mild cognitive impairment is higher in men. The Mayo Clinic Study of Aging. Neurology. 2010;75:889-897. doi: 10.1212/WNL.0b013e3181f11d85.
5. Wolf PA, D'Agostino RB, Belanger AJ, Kannel WB. Probability of stroke: a risk profile from the Framingham Study. Stroke. 1991;22:312-318.
6. Norton S, Matthews FE, Barnes DE, Yaffe K, Brayne C. Potential for primary prevention of Alzheimer's disease: an analysis of population-based data. Lancet Neurol. 2014;13:788-794. doi: 10.1016/S1474-4422(14)70136-X.
7. Lloyd-Jones DM, Hong Y, Labarthe D, Mozaffarian D, Appel LJ, Van Horn L, et al; American Heart Association Strategic Planning Task Force and Statistics Committee. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond. Circulation. 2010;121:586-613. doi: 10.1161/CIRCULATIONAHA.109.192703.
8. Xanthakis V, Enserro DM, Murabito JM, Polak JF, Wollert KC, Januzzi JL, et al. Ideal cardiovascular health: associations with biomarkers and subclinical disease and impact on incidence of cardiovascular disease in the Framingham Offspring Study. Circulation. 2014;130:1676-1683. doi: 10.1161/CIRCULATIONAHA.114.009273.
9. Dong C, Rundek T, Wright CB, Anwar Z, Elkind MS, Sacco RL. Ideal cardiovascular health predicts lower risks of myocardial infarction, stroke, and vascular death across whites, blacks, and hispanics: the northern Manhattan study. Circulation. 2012;125:2975-2984. doi: 10.1161/CIRCULATIONAHA.111.081083.
10. Zhang Q, Zhou Y, Gao X, Wang C, Zhang S, Wang A, et al. Ideal cardiovascular health metrics and the risks of ischemic and intracerebral hemorrhagic stroke. Stroke. 2013;44:2451-2456. doi: 10.1161/STROKEAHA.113.678839.
11. Gorelick PB, Scuteri A, Black SE, Decarli C, Greenberg SM, Iadecola C, et al; American Heart Association Stroke Council, Council on Epidemiology and Prevention, Council on Cardiovascular Nursing, Council on Cardiovascular Radiology and Intervention, and Council on Cardiovascular Surgery and Anesthesia. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke. 2011;42:2672-2713. doi: 10.1161/STR.0b013e3182299496.
12. Feinleib M, Kannel WB, Garrison RJ, McNamara PM, Castelli WP. The Framingham Offspring Study. Design and preliminary data. Prev Med. 1975;4:518-525.
13. Wolf PA. Contributions of the Framingham Heart Study to stroke and dementia epidemiologic research at 60 years. Arch Neurol. 2012;69:567-571. doi: 10.1001/archneurol.2011.977.
14. Qiu C, Winblad B, Fratiglioni L. The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol. 2005;4:487-499. doi: 10.1016/S1474-4422(05)70141-1.
15. American Psychatric Association. Diagnostic and Statistical Manual of Mental Disorders 4th ed. Text Revision. 4th ed. Washington DC: American Psychatric Assocaition; 2000.
16. Graham NL, Emery T, Hodges JR. Distinctive cognitive profiles in Alzheimer's disease and subcortical vascular dementia. J Neurol Neurosurg Psychiatry. 2004;75:61-71.
17. De Carli C, Massaro J, Harvey D, Hald J, Tullberg M, Au R, et al. Measures of brain morphology and infarction in the framingham heart study: establishing what is normal. Neurobiol Aging. 2005;26:491-510. doi: 10.1016/j.neurobiolaging.2004.05.004.
18. Crichton GE, Elias MF, Davey A, Alkerwi A. Cardiovascular health and cognitive function: the Maine-Syracuse Longitudinal Study. PLoS One. 2014;9:e89317. doi: 10.1371/journal.pone.0089317.
19. Seshadri S, Wolf PA, Beiser AS, Selhub J, Au R, Jacques PF, et al. Association of plasma total homocysteine levels with subclinical brain injury: cerebral volumes, white matter hyperintensity, and silent brain infarcts at volumetric magnetic resonance imaging in the Framingham Offspring Study. Arch Neurol. 2008;65:642-649. doi: 10.1001/archneur.65.5.642.
20. Debette S, Beiser A, Hoffmann U, Decarli C, O'Donnell CJ, Massaro JM, et al. Visceral fat is associated with lower brain volume in healthy middle-aged adults. Ann Neurol. 2010;68:136-144. doi: 10.1002/ana.22062.
21. Hopkins RO, Beck CJ, Burnett DL, Weaver LK, Victoroff J, Bigler ED. Prevalence of white matter hyperintensities in a young healthy population. J Neuroimaging. 2006;16:243-251. doi: 10.1111/j.1552-6569.2006.00047.x.
22. Jack CR Jr, Knopman DS, Jagust WJ, Petersen RC, Weiner MW, Aisen PS, et al. Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol. 2013;12:207-216. doi: 10.1016/S1474-4422(12)70291-0.
23. Rosenberg RN, Petersen RC. The Human Alzheimer Disease Project: a new call to arms. JAMA Neurol. 2015;72:626-628. doi: 10.1001/jamaneurol.2015.67.
24. Larson EB, Yaffe K, Langa KM. New insights into the dementia epidemic. N Engl J Med. 2013;369:2275-2277. doi: 10.1056/NEJMp1311405.
25. Kling MA, Trojanowski JQ, Wolk DA, Lee VM, Arnold SE. Vascular disease and dementias: paradigm shifts to drive research in new directions. Alzheimers Dement. 2013;9:76-92. doi: 10.1016/j.jalz.2012.02.007.
26. Langa KM. Is the risk of Alzheimer's disease and dementia declining? Alzheimers Res Ther. 2015;7:34. doi: 10.1186/s13195-015-0118-1.
27. Societies can both grow old and lower dementia burden. Lancet Neurol. 2015;14:967. doi: 10.1016/S1474-4422(15)00223-9.